Nasal Trivalent Vaccine Against Seasonal Flu For The 2024/2025 Flu Season

Folkehelseinstituttet Norway has Released a tender for Nasal Trivalent Vaccine Against Seasonal Flu For The 2024/2025 Flu Season in Pharmaceuticals. The tender was released on Aug 16, 2024.

Country - Norway

Summary - Nasal Trivalent Vaccine Against Seasonal Flu For The 2024/2025 Flu Season

Deadline - login to view

MT reference number - 90964411

Product classification - Influenza vaccines

Organization Details:

  Address - Norway

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 90964411

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The Norwegian Institute of Public Health (FHI) has procured nasal trivalent vaccine against seasonal influenza (ATC J07B B03) for vaccination of persons in defined risk groups aged 2-17 years. The procurement included 6,000 (six thousand ) vaccine doses. One offer was received in the competition. This offer was from Astra Zeneca AS, which was awarded the contract. Regarding changes in organization and responsibility for procurement of vaccines for national vaccination programs in Norway: The Ministry of Health and Welfare has decided that organization and responsibility for vaccine procurement will change from 01.01.2024. The procurement has been carried out by FHI in the same wa

Mt Ref Id - 90964411

Deadline - Nov 30, -0001

Share

Similar Tenders :